Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

No more siloes: linking rheumatology and CVD with Abcentra

Although there are evidence-based links between CVD and inflammatory conditions, and associated strong risk factors, they are often ignored when treating patients with either type of condition. Abcentra former CEO and current senior advisor Bert Liang wants to break through the physician and treatment siloes and develop a drug that treats the inflammatory cause of certain CVD conditions.


Go Top